TickerFacts.

TScan Therapeutics, Inc. (TCRX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

129.78M
Year ended 2025-12-31
+75.4%
3-year compound annual growth
2021-12-31: 11.66M2022-12-31: 24.05M2023-12-31: 65.60M2024-12-31: 111.99M2025-12-31: 129.78M129.78M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31129.78M+15.9%2026-03-04, From 2025-01-01
2024-12-31111.99M+70.7%2026-03-04, From 2024-01-01
2023-12-3165.60M+172.8%2025-03-05, From 2023-01-01
2022-12-3124.05Mn/c2024-03-06, From 2022-01-01
2021-12-3111.66Mn/a2023-03-08, From 2021-01-01